Imunon Inc Stock Price Patterns
| IMNN Stock | USD 3.31 0.09 2.65% |
Momentum 45
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (2.57) | EPS Estimate Current Year (18.52) | EPS Estimate Next Year (3.50) | Wall Street Target Price 24.3333 | EPS Estimate Current Quarter (1.82) |
Using Imunon hype-based prediction, you can estimate the value of Imunon Inc from the perspective of Imunon response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Imunon to buy its stock at a price that has no basis in reality. In that case, they are not buying Imunon because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Imunon after-hype prediction price | USD 3.31 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Imunon Basic Forecasting Models to cross-verify your projections. Imunon After-Hype Price Density Analysis
As far as predicting the price of Imunon at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Imunon or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Imunon, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Imunon Estimiated After-Hype Price Volatility
In the context of predicting Imunon's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Imunon's historical news coverage. Imunon's after-hype downside and upside margins for the prediction period are 0.17 and 7.71, respectively. We have considered Imunon's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Imunon is risky at this time. Analysis and calculation of next after-hype price of Imunon Inc is based on 3 months time horizon.
Imunon Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Imunon is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Imunon backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Imunon, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.37 | 4.42 | 0.06 | 0.03 | 2 Events / Month | 5 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
3.31 | 3.31 | 0.00 |
|
Imunon Hype Timeline
Imunon Inc is currently traded for 3.31. The entity has historical hype elasticity of 0.06, and average elasticity to hype of competition of 0.03. Imunon is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is estimated to be very small, whereas the daily expected return is currently at -0.37%. %. The volatility of related hype on Imunon is about 5525.0%, with the expected price after the next announcement by competition of 3.34. The book value of the company was currently reported as 1.41. The company recorded a loss per share of 12.53. Imunon Inc had not issued any dividends in recent years. The entity had 115:100 split on the 7th of August 2025. Given the investment horizon of 90 days the next estimated press release will be in a few days. Check out Imunon Basic Forecasting Models to cross-verify your projections.Imunon Related Hype Analysis
Having access to credible news sources related to Imunon's direct competition is more important than ever and may enhance your ability to predict Imunon's future price movements. Getting to know how Imunon's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Imunon may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SNSE | Sensei Biotherapeutics | (0.02) | 6 per month | 5.92 | 0.01 | 17.33 | (10.69) | 36.61 | |
| DWTX | Dogwood Therapeutics | (0.02) | 4 per month | 0.00 | (0.14) | 7.78 | (11.30) | 33.43 | |
| BOLT | Bolt Biotherapeutics | 0.15 | 14 per month | 4.05 | 0.02 | 8.22 | (7.17) | 18.19 | |
| EVGN | Evogene | 0.15 | 15 per month | 0.00 | (0.09) | 3.77 | (5.22) | 21.65 | |
| CLRB | Cellectar Biosciences | 0.15 | 12 per month | 0.00 | (0.03) | 7.66 | (10.25) | 30.55 | |
| COCP | Cocrystal Pharma | (0.01) | 9 per month | 3.00 | (0.01) | 7.45 | (6.36) | 18.39 | |
| AEON | AEON Biopharma | (0.05) | 8 per month | 5.39 | 0.08 | 10.34 | (8.54) | 33.74 | |
| CING | Cingulate | 0.15 | 2 per month | 4.40 | 0.14 | 7.46 | (6.75) | 18.80 | |
| MRKR | Marker Therapeutics | 0.15 | 2 per month | 5.11 | 0.13 | 12.79 | (8.63) | 28.69 | |
| TRAW | Traws Pharma | 0.15 | 13 per month | 8.74 | 0.01 | 17.70 | (12.90) | 58.96 |
Imunon Additional Predictive Modules
Most predictive techniques to examine Imunon price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Imunon using various technical indicators. When you analyze Imunon charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Imunon Predictive Indicators
The successful prediction of Imunon stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Imunon Inc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Imunon based on analysis of Imunon hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Imunon's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Imunon's related companies. | 2025 | 2026 (projected) | Days Sales Outstanding | 108.24 | 176.96 | PTB Ratio | 2.67 | 2.8 |
Pair Trading with Imunon
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Imunon position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Imunon will appreciate offsetting losses from the drop in the long position's value.Moving together with Imunon Stock
Moving against Imunon Stock
| 0.76 | CUB | Lionheart Holdings | PairCorr |
| 0.71 | LION | Lionsgate Studios Holding | PairCorr |
| 0.67 | JRVR | James River Group | PairCorr |
| 0.65 | UPB | Upstream Bio | PairCorr |
| 0.6 | ARDX | Ardelyx Sell-off Trend | PairCorr |
| 0.58 | KNYJF | KONE Oyj Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Imunon could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Imunon when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Imunon - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Imunon Inc to buy it.
The correlation of Imunon is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Imunon moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Imunon Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Imunon can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Imunon Basic Forecasting Models to cross-verify your projections. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Will Biotechnology sector continue expanding? Could Imunon diversify its offerings? Factors like these will boost the valuation of Imunon. Market participants price Imunon higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Imunon data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Imunon Inc requires distinguishing between market price and book value, where the latter reflects Imunon's accounting equity. The concept of intrinsic value—what Imunon's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Imunon's price substantially above or below its fundamental value.
Please note, there is a significant difference between Imunon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Imunon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Imunon's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.